Detalles de la búsqueda
1.
Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Support Care Cancer
; 29(9): 5197-5207, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33625586
2.
Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Br J Haematol
; 178(1): 61-71, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28382618
3.
Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation.
Blood
; 126(8): 1027-32, 2015 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-26160301
4.
Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma.
Blood
; 123(7): 985-91, 2014 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24227817
5.
Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial.
Ann Hematol
; 94(4): 593-601, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25387663
6.
Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis.
Biol Blood Marrow Transplant
; 20(11): 1841-6, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24946719
7.
Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation.
Br J Haematol
; 166(5): 749-57, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24961645
8.
Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.
Ann Hematol
; 93(3): 459-62, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24441915
9.
Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Ann Hematol
; 93(11): 1825-38, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24951123
10.
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.
Blood
; 117(23): 6375-82, 2011 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-21467544
11.
Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.
Haematologica
; 98(2): 264-8, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22983582
12.
Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial.
Biol Blood Marrow Transplant
; 18(11): 1716-26, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22713691
13.
European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies.
J Antimicrob Chemother
; 67(8): 2029-33, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22566591
14.
Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia.
Haematologica
; 97(2): 246-50, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21993668
15.
Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies.
Med Mycol
; 50(3): 266-9, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21905944
16.
Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases.
Onkologie
; 35(7-8): 447-50, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22846978
17.
Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo.
Blood
; 113(26): 6716-25, 2009 Jun 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-19321860
18.
Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program.
Transfusion
; 51(5): 968-75, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20880037
19.
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
Lancet Oncol
; 10(9): 855-64, 2009 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-19695955
20.
Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation.
Clin Ther
; 31(2): 386-98, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19302911